Pharmacological influences on aldosterone secretion.
Besides the classical modulators of aldosterone secretion, new factors influencing positively or negatively aldosterone secretion have been described. These new factors and the effect of related drugs constitutes the aim of this review. The effect of dopamine agonists and H2-receptor antagonists on aldosterone secretion in normal volunteers as well as in different clinical situations characterized by an increased production of aldosterone opens a new field of investigation for the therapy of aldosterone secretion alterations.
D000450:Aldosterone / Q000378:metabolism*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology; D010907:Pituitary Hormones / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D012083:Renin / Q000097:blood; D012701:Serotonin / Q000494:pharmacology
D000451:Mineralocorticoid Receptor Antagonists; D010907:Pituitary Hormones; D000804:Angiotensin II; D012701:Serotonin; D000450:Aldosterone; D006632:Histamine; D009320:Atrial Natriuretic Factor; D012083:Renin; D011188:Potassium; D004298:Dopamine